ATLAS fair value
₩20,205
Below fair value · 49% discount
Whanin Pharm stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Korea Exchange (KOSPI) · South Korea
Prices as of Oct 27, 2026 · KRW
₩20,205
Below fair value · 49% discount
54%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Whanin Pharm's fair value at about ₩20,205 per share (reasonable range: ₩14,275 to ₩28,599). At ₩10,230, the stock trades 49% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Whanin Pharm a 54% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩9,982 and ₩10,582; in 9 out of 10, between ₩9,480 and ₩11,143. Estimated annual volatility is 15%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Whanin Pharm sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 016580.KO has traded between ₩9,160 and ₩12,140. Today it is 15.7% below that high and 12% above its low.
On the business: net margin is 7.5%; it trades at 9.4 times earnings.
Its beta is 0.17: it tends to move less than the market.
Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea.
Want to see everything about Whanin Pharm?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About ₩20,205 per share according to ATLAS (reasonable range: ₩14,275 to ₩28,599). With the stock at ₩10,230, it is 49% below it.
54%: close to a coin flip. In half of the simulated outcomes, 016580.KO ends the month between ₩9,982 and ₩10,582.
Whanin Pharm's market capitalization is ₩190B. Its price-to-earnings (P/E) ratio is 9.4: you pay ₩9.36 for each ₩1.00 of yearly earnings.
Yes. 016580.KO's current dividend yield is 2.90% at today's price (₩10,230).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy